UMIN ID: C000000358
Registered date:01/04/2006
A Phase II study of induction chemotherapy S-1 and CDDP in patients with FDG-PET positive N2 disease of non-small cell lung cancer.
Basic Information
| Recruitment status | |
|---|---|
| Health condition(s) or Problem(s) studied | Non small cell lung cancer |
| Date of first enrollment | 2006/04/01 |
| Target sample size | 25 |
| Countries of recruitment | Japan |
| Study type | Interventional |
| Intervention(s) | Chemotherapy |
Outcome(s)
| Primary Outcome | Response rate |
|---|---|
| Secondary Outcome | adverse event, over all survival, recurrence-free survival rate, effectiveness of evaluation by PET scan |
Key inclusion & exclusion criteria
| Age minimum | 20years-old |
|---|---|
| Age maximum | 75years-old |
| Gender | Male and Female |
| Include criteria | |
| Exclude criteria | 1. active interstitial pneumonia 2. active infectious disease 3. active other cancer 4. severe drug allergy 5. severe complications |
Related Information
| Primary Sponsor | Fukushima Medical University |
|---|---|
| Secondary Sponsor | Fukushima Red cross hospitalIwaki public hospitalSouthern Tohoku general hospitalYonezawa city hospitalSirakawa kosei hospital |
| Source(s) of Monetary Support | None |
| Secondary ID(s) |
Contact
| public contact | |
| Name | Hiroyuki Suzuki |
| Address | 960-12951 Hikarigaoka Fukushima, Fukushima Japan |
| Telephone | 024-547-1254 |
| hiro@fmu.ac.jp | |
| Affiliation | Fukushima Medical University Department of Surgery 1 |
| scientific contact | |
| Name | Hiroyuki Suzuki |
| Address | 960-12951 Hikarigaoka Fukushima, Fukushima Japan |
| Telephone | 024-547-1254 |
| Affiliation | Fukushima Medical University Department of Surgery 1 |